Initiating Clozapine Treatment in the Outpatient Clinic: Service Utilization and Cost Trends
- 1 August 1998
- journal article
- Published by American Psychiatric Association Publishing in Psychiatric Services
- Vol. 49 (8) , 1034-1038
- https://doi.org/10.1176/ps.49.8.1034
Abstract
Clozapine has been shown to be a cost-effective treatment for refractory psychosis among patients started on the medication in a hospital setting. The study examined service utilization and costs associated with clozapine treatment initiated in an outpatient clinic.Keywords
This publication has 17 references indexed in Scilit:
- The clozapine clinicThe Lancet, 1996
- Cost‐effectiveness of clozapine treatment in therapy‐refractory schizophreniaActa Psychiatrica Scandinavica, 1995
- Cost effectiveness of clozapine in neuroleptic-resistant schizophreniaAmerican Journal of Psychiatry, 1993
- Clozapine Use by State Programs: Public Mental Health Systems Respond to a New MedicationPsychiatric Services, 1993
- New Drugs for the Treatment of SchizophreniaPsychiatric Clinics of North America, 1993
- Effects of Six Months of Clozapine Treatment on the Quality of Life of Chronic Schizophrenic PatientsPsychiatric Services, 1990
- A Two-Year Clinical and Economic Follow-Up of Patients on ClozapinePsychiatric Services, 1990
- Cost-Effectiveness of Clozapine for Treatment-Resistant Schizophrenic PatientsPsychiatric Services, 1990
- Clozapine for the Treatment-Resistant SchizophrenicArchives of General Psychiatry, 1988
- The Quality of Life Scale: An Instrument for Rating the Schizophrenic Deficit SyndromeSchizophrenia Bulletin, 1984